Site professionnel spécialisé en Rhumatologie
SOMMAIRE Spondyloarthrite axiale : efficacité thérapeutique, facteurs associés... Pr Daniel Wendling (Besancon) Rhumatisme pédiatrique : des nouveautés en thérapeutique Pr Valérie Devauchelle (Brest) Polyarthrite rhumatoïde : traitements préventifs de la…
OP0185. Unizony S, Matza M, Jarvie A et al. Tocilizumab in combination with 8 weeks of prednisone for giant cell arteritis. Eular 2022.
OP0019. Van des Heijde D, Baraliakos X, Dougados M et al. Bimekizumab in patients with active ankylosing spondylitis: 24-week efficacy & safety from BE MOBILE 2, a phase 3, multicentre,…
OP0025. Rahman P, Mease PJ, Deodhar A et al. Factors associated with fatigue and its improvement – a principal component analysis of patients with active psoriatic arthritis from guselkumab phase…
OP0027. Kristensen LE, Strober B, Poddubnyy D et al. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and…
